{"id":59400,"date":"2024-05-21T01:04:12","date_gmt":"2024-05-20T23:04:12","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/afya-limited-the-company-notice-of-annual-general-meeting-of-the-company\/"},"modified":"2024-05-21T01:04:12","modified_gmt":"2024-05-20T23:04:12","slug":"afya-limited-the-company-notice-of-annual-general-meeting-of-the-company","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/afya-limited-the-company-notice-of-annual-general-meeting-of-the-company\/","title":{"rendered":"Afya Limited (the &#8220;Company&#8221;) Notice of Annual General Meeting of the Company"},"content":{"rendered":"<div>\n<p>NOVA LIMA, Brazil&#8211;(BUSINESS WIRE)&#8211;Notice is hereby given that an Annual General Meeting of the Company (the &#8220;<b>AGM<\/b>&#8220;) will be held at the offices of Afya Participa\u00e7\u00f5es S.A. (Nasdaq: AFYA; B3: A2FY34) (the &#8220;<b>Company<\/b>&#8220;), Alameda Oscar Niemeyer, No. 119, 15th Floor, Vila da Serra, Nova Lima, Minas Gerais, Brazil, Zip Code: 34.006-056, and virtually by accessing the following link <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fweb.lumiconnect.com%2F283874046&amp;esheet=54004751&amp;newsitemid=20240520214893&amp;lan=en-US&amp;anchor=https%3A%2F%2Fweb.lumiconnect.com%2F283874046&amp;index=1&amp;md5=b13c97aaa266b296dfb0575c566651f3\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/web.lumiconnect.com\/283874046<\/a> (password: afya2024), on the 5<sup>th<\/sup> day of June 2024 at 10:00 a.m. BRT, for the purpose of considering and, if thought fit, passing and approving the following resolution:<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20240520214893\/en\/1927844\/5\/AF-LOGO-AFYA-POSITIVO.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240520214893\/en\/1927844\/22\/AF-LOGO-AFYA-POSITIVO.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20240520214893\/en\/1927844\/5\/AF-LOGO-AFYA-POSITIVO.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240520214893\/en\/1927844\/21\/AF-LOGO-AFYA-POSITIVO.jpg\"><\/a><\/p>\n<table cellspacing=\"0\" class=\"bwtablemarginb bwblockalignl bwwidth100\">\n<tr>\n<td class=\"bwvertalignt bwpadl0 bwwidth1\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwvertalignt bwpadl0 bwwidth1\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n1.<\/p>\n<\/td>\n<td class=\"bwvertalignt bwpadl0 bwwidth98\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n&#8220;As an ordinary resolution, that the Company&#8217;s financial statements and the auditor&#8217;s report for the fiscal year ended December 31, 2023 be approved and ratified.&#8221;<\/p>\n<\/td>\n<\/tr>\n<\/table>\n<p>\nThe AGM will also serve as an opportunity for shareholders to discuss Company affairs with management.<\/p>\n<p>\nShareholders may participate in the AGM virtually by accessing the following link <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fweb.lumiconnect.com%2F283874046&amp;esheet=54004751&amp;newsitemid=20240520214893&amp;lan=en-US&amp;anchor=https%3A%2F%2Fweb.lumiconnect.com%2F283874046&amp;index=2&amp;md5=4d0557255d9c019c140d8ced23d8679f\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/web.lumiconnect.com\/283874046<\/a> (password: afya2024). Participation by a shareholder in the AGM in this manner shall be treated as presence in person at the AGM and such shareholder shall be counted in a quorum and entitled to vote in accordance with Article 18.3 of the Articles of Association of the Company.<\/p>\n<p>\nThe Board of Directors of the Company (the &#8220;<b>Board<\/b>&#8220;) has fixed the close of business, BRT, on May 10, 2024, BRT, as the record date (the \u201c<b>Record Date<\/b>\u201d) for determining the shareholders of the Company entitled to receive notice of the AGM or any adjournment thereof. The holders of record of the Class A common shares and the Class B common shares of the Company as at the close of business, BRT, on the Record Date are entitled to receive notice of and attend the AGM and any adjournment thereof.<\/p>\n<p>\nThe Company\u2019s 2023 Financial Statements for the fiscal year ended December 31, 2023 was filed with the U.S. Securities and Exchange Commission on March 14, 2024 (the \u201c<b>Financial Statements<\/b>\u201d). Shareholders may obtain a copy of the Financial Statements, free of charge, from the Company\u2019s website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fir.afya.com.br&amp;esheet=54004751&amp;newsitemid=20240520214893&amp;lan=en-US&amp;anchor=https%3A%2F%2Fir.afya.com.br&amp;index=3&amp;md5=1eb50118517734a1be4f403f055bc197\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/ir.afya.com.br<\/a> or by contacting the Company\u2019s Investor Relations Department by email at <a target=\"_blank\" href=\"&#109;&#x61;i&#x6c;t&#111;&#x3a;&#105;&#x72;&#64;&#97;&#x66;&#121;&#x61;&#46;&#x63;&#x6f;&#109;&#x2e;b&#x72;\" rel=\"nofollow noopener\" shape=\"rect\">i&#114;&#64;&#97;&#x66;&#x79;&#x61;&#46;c&#111;&#109;&#x2e;&#x62;&#x72;<\/a>.<\/p>\n<p>\nThe Board recommends that shareholders of the Company vote \u201cFOR\u201d the resolutions at the AGM. Your vote is very important to the Company.<\/p>\n<p>\nWhether or not you plan to attend the AGM, please promptly complete, date, sign and return the proxy card attached to this Notice.<\/p>\n<p>\nBy order of the Board<\/p>\n<table cellspacing=\"0\" class=\"bwtablemarginb bwblockalignl bwwidth100\">\n<tr>\n<td class=\"bwvertalignt bwsinglebottom bwpadl0 bwwidth20\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n\/s\/ Kay Kraft<\/p>\n<\/td>\n<td class=\"bwvertalignt bwpadl0 bwwidth80\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n\u00a0<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0 bwwidth20\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nKay Kraft<\/p>\n<\/td>\n<td class=\"bwvertalignt bwpadl0 bwwidth80\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n\u00a0<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0 bwwidth20\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nDirector<\/p>\n<\/td>\n<td class=\"bwvertalignt bwpadl0 bwwidth80\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n\u00a0<\/p>\n<\/td>\n<\/tr>\n<\/table>\n<p>\nMay 17, 2024<\/p>\n<p>\nRegistered Office:<br \/>\n<br \/>c\/o Maples Corporate Services Limited<br \/>\n<br \/>PO Box 309, Ugland House<br \/>\n<br \/>Grand Cayman<br \/>\n<br \/>KY1-1104<\/p>\n<p>\nCayman Islands<\/p>\n<p>\n*A form of proxy has been included with this Notice.<\/p>\n<p>\n______________________________________________________________________________________________________________________<\/p>\n<p>\n<b>NOTES<\/b><\/p>\n<p>\n<b>IF YOU HAVE EXECUTED A STANDING PROXY, YOUR STANDING PROXY WILL BE VOTED AS INDICATED IN NOTE 2 BELOW, UNLESS YOU ATTEND THE AGM IN PERSON OR SEND IN A SPECIFIC PROXY.<\/b><\/p>\n<table cellspacing=\"0\" class=\"bwtablemarginb bwblockalignl bwwidth100\">\n<tr>\n<td class=\"bwvertalignt bwpadl0 bwwidth1\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwpadl0 bwpadr0 bwvertalignt bwwidth2 bwalignl\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin bwalignl\">\n1<\/p>\n<\/td>\n<td class=\"bwvertalignt bwpadl0 bwwidth97\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nA proxy need not be a shareholder of the Company. A shareholder entitled to attend and vote at the AGM is entitled to appoint one or more proxies to attend and vote in his\/her stead.<\/p>\n<\/td>\n<\/tr>\n<\/table>\n<table cellspacing=\"0\" class=\"bwtablemarginb bwblockalignl bwwidth100\">\n<tr>\n<td class=\"bwvertalignt bwpadl0 bwwidth1\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwpadl0 bwpadr0 bwvertalignt bwwidth2 bwalignl\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin bwalignl\">\n2<\/p>\n<\/td>\n<td class=\"bwvertalignt bwpadl0 bwwidth97\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nAny standing proxy previously deposited by a shareholder with the Company will be voted in favour of the resolutions to be proposed at the AGM unless revoked prior to the AGM or the shareholder attends the AGM in person or executes a specific proxy.<\/p>\n<\/td>\n<\/tr>\n<\/table>\n<table cellspacing=\"0\" class=\"bwtablemarginb bwblockalignl bwwidth100\">\n<tr>\n<td class=\"bwvertalignt bwpadl0 bwwidth1\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwpadl0 bwpadr0 bwvertalignt bwwidth2 bwalignl\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin bwalignl\">\n3<\/p>\n<\/td>\n<td class=\"bwvertalignt bwpadl0 bwwidth97\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nA form of proxy for use at the AGM is enclosed. Whether or not you propose to attend the AGM in person, you are strongly advised to complete and sign the enclosed form of proxy in accordance with the instructions printed on it and then deposit it (together with any power of attorney or other authority under which it is signed or a notarially certified copy of that power or authority) at the offices of Afya Participa\u00e7\u00f5es S.A., Alameda Oscar Niemeyer, No. 119, 15th Floor, Vila da Serra, Nova Lima, Minas Gerais, Brazil, Zip Code: 34.006-056, or send copies of the foregoing by email to <a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#x74;&#x6f;&#x3a;&#x69;&#x72;&#x40;&#x61;&#x66;&#x79;&#x61;&#x2e;&#x63;&#x6f;&#x6d;&#x2e;&#x62;&#x72;\" rel=\"nofollow noopener\" shape=\"rect\">i&#114;&#x40;&#x61;f&#121;&#97;&#x2e;&#x63;o&#109;&#46;&#x62;&#x72;<\/a>, in each case marked for the attention of Renata Couto, Anibal Sousa and Rodrigo Proen\u00e7a, not later than 11:59 p.m. BRT on the business day prior to the date of the AGM or adjourned AGM in accordance with the Amended and Restated Articles of Association of the Company. Returning the completed form of proxy will not preclude you from attending the AGM and voting in person if you so wish.<\/p>\n<\/td>\n<\/tr>\n<\/table>\n<table cellspacing=\"0\" class=\"bwtablemarginb bwblockalignl bwwidth100\">\n<tr>\n<td class=\"bwvertalignt bwpadl0 bwwidth1\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwpadl0 bwpadr0 bwvertalignt bwwidth2 bwalignl\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin bwalignl\">\n4<\/p>\n<\/td>\n<td class=\"bwvertalignt bwpadl0 bwwidth97\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nIf two or more persons are jointly registered as holders of a share, the vote of the senior person who tenders a vote, whether in person or by proxy, shall be accepted to the exclusion of the votes of other joint holders. For this purpose seniority shall be determined by the order in which the names stand on the Company&#8217;s register of shareholders in respect of the relevant shares.<\/p>\n<\/td>\n<\/tr>\n<\/table>\n<table cellspacing=\"0\" class=\"bwtablemarginb bwblockalignl bwwidth100\">\n<tr>\n<td class=\"bwvertalignt bwpadl0 bwwidth1\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwpadl0 bwpadr0 bwvertalignt bwwidth2 bwalignl\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin bwalignl\">\n5<\/p>\n<\/td>\n<td class=\"bwvertalignt bwpadl0 bwwidth97\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nA shareholder holding more than one share entitled to attend and vote at the AGM need not cast the votes in respect of such shares in the same way on any resolution and therefore may vote a share or some or all such shares either for or against a resolution and\/or abstain from voting a share or some or all of the shares and, subject to the terms of the instrument appointing any proxy, a proxy appointed under one or more instruments may vote a share or some or all of the shares in respect of which he is appointed either for or against a resolution and\/or abstain from voting.<\/p>\n<\/td>\n<\/tr>\n<\/table>\n<table cellspacing=\"0\" class=\"bwtablemarginb bwblockalignl bwwidth100\">\n<tr>\n<td class=\"bwvertalignt bwpadl0 bwwidth1\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwpadl0 bwpadr0 bwvertalignt bwwidth2 bwalignl\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin bwalignl\">\n6<\/p>\n<\/td>\n<td class=\"bwvertalignt bwpadl0 bwwidth97\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nNo business shall be transacted at the AGM unless a quorum is present at the time when the meeting proceeds to business. One or more Members holding not less than one-third in aggregate of the voting power of all Shares in issue and entitled to vote, present in person or by proxy or, if a corporation or other non-natural Person, by its duly authorised representative, shall represent a quorum.<\/p>\n<\/td>\n<\/tr>\n<\/table>\n<p>\n\u00a0<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Investor Contact:<\/b>\u00a0<a target=\"_blank\" href=\"&#x6d;&#97;i&#x6c;&#x74;&#111;:&#x69;&#x72;&#64;a&#x66;&#x79;&#97;&#46;&#x63;&#x6f;&#109;&#46;&#x62;&#114;\" rel=\"nofollow noopener\" shape=\"rect\">&#x69;&#x72;&#x40;&#x61;&#x66;&#x79;&#x61;&#x2e;&#x63;&#x6f;&#x6d;&#46;&#98;&#114;<\/a><br \/><b>IR Website:<\/b>\u00a0<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fir.afya.com.br%2F&amp;esheet=54004751&amp;newsitemid=20240520214893&amp;lan=en-US&amp;anchor=ir.afya.com.br&amp;index=4&amp;md5=b38adb4c49f9b71be5c8645085c617d2\" rel=\"nofollow noopener\" shape=\"rect\">ir.afya.com.br<\/a><\/p>\n<p>\n<b>Media Contact:<\/b><br \/>C\u00edntia Moraes Marin<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;t&#x6f;:&#99;&#x69;&#110;&#x74;i&#x61;&#46;&#109;&#x61;&#114;&#x69;n&#x40;a&#102;&#x79;&#97;&#x2e;c&#x6f;m&#46;&#x62;&#114;\" rel=\"nofollow noopener\" shape=\"rect\">&#99;&#x69;&#x6e;t&#105;&#x61;&#x2e;m&#97;&#x72;i&#110;&#x40;&#x61;f&#121;&#x61;&#46;&#99;&#x6f;&#x6d;&#46;&#98;&#x72;<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>NOVA LIMA, Brazil&#8211;(BUSINESS WIRE)&#8211;Notice is hereby given that an Annual General Meeting of the Company (the &#8220;AGM&#8220;) will be held at the offices of Afya Participa\u00e7\u00f5es S.A. (Nasdaq: AFYA; B3: A2FY34) (the &#8220;Company&#8220;), Alameda Oscar Niemeyer, No. 119, 15th Floor, Vila da Serra, Nova Lima, Minas Gerais, Brazil, Zip Code: 34.006-056, and virtually by accessing &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/afya-limited-the-company-notice-of-annual-general-meeting-of-the-company\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-59400","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Afya Limited (the &quot;Company&quot;) Notice of Annual General Meeting of the Company - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/afya-limited-the-company-notice-of-annual-general-meeting-of-the-company\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Afya Limited (the &quot;Company&quot;) Notice of Annual General Meeting of the Company - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"NOVA LIMA, Brazil&#8211;(BUSINESS WIRE)&#8211;Notice is hereby given that an Annual General Meeting of the Company (the &#8220;AGM&#8220;) will be held at the offices of Afya Participa\u00e7\u00f5es S.A. (Nasdaq: AFYA; B3: A2FY34) (the &#8220;Company&#8220;), Alameda Oscar Niemeyer, No. 119, 15th Floor, Vila da Serra, Nova Lima, Minas Gerais, Brazil, Zip Code: 34.006-056, and virtually by accessing ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/afya-limited-the-company-notice-of-annual-general-meeting-of-the-company\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-20T23:04:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20240520214893\/en\/1927844\/22\/AF-LOGO-AFYA-POSITIVO.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-the-company-notice-of-annual-general-meeting-of-the-company\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-the-company-notice-of-annual-general-meeting-of-the-company\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Afya Limited (the &#8220;Company&#8221;) Notice of Annual General Meeting of the Company\",\"datePublished\":\"2024-05-20T23:04:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-the-company-notice-of-annual-general-meeting-of-the-company\\\/\"},\"wordCount\":1016,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-the-company-notice-of-annual-general-meeting-of-the-company\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240520214893\\\/en\\\/1927844\\\/22\\\/AF-LOGO-AFYA-POSITIVO.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-the-company-notice-of-annual-general-meeting-of-the-company\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-the-company-notice-of-annual-general-meeting-of-the-company\\\/\",\"name\":\"Afya Limited (the \\\"Company\\\") Notice of Annual General Meeting of the Company - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-the-company-notice-of-annual-general-meeting-of-the-company\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-the-company-notice-of-annual-general-meeting-of-the-company\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240520214893\\\/en\\\/1927844\\\/22\\\/AF-LOGO-AFYA-POSITIVO.jpg\",\"datePublished\":\"2024-05-20T23:04:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-the-company-notice-of-annual-general-meeting-of-the-company\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-the-company-notice-of-annual-general-meeting-of-the-company\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-the-company-notice-of-annual-general-meeting-of-the-company\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240520214893\\\/en\\\/1927844\\\/22\\\/AF-LOGO-AFYA-POSITIVO.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240520214893\\\/en\\\/1927844\\\/22\\\/AF-LOGO-AFYA-POSITIVO.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-the-company-notice-of-annual-general-meeting-of-the-company\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Afya Limited (the &#8220;Company&#8221;) Notice of Annual General Meeting of the Company\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Afya Limited (the \"Company\") Notice of Annual General Meeting of the Company - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/afya-limited-the-company-notice-of-annual-general-meeting-of-the-company\/","og_locale":"en_US","og_type":"article","og_title":"Afya Limited (the \"Company\") Notice of Annual General Meeting of the Company - Pharma Trend","og_description":"NOVA LIMA, Brazil&#8211;(BUSINESS WIRE)&#8211;Notice is hereby given that an Annual General Meeting of the Company (the &#8220;AGM&#8220;) will be held at the offices of Afya Participa\u00e7\u00f5es S.A. (Nasdaq: AFYA; B3: A2FY34) (the &#8220;Company&#8220;), Alameda Oscar Niemeyer, No. 119, 15th Floor, Vila da Serra, Nova Lima, Minas Gerais, Brazil, Zip Code: 34.006-056, and virtually by accessing ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/afya-limited-the-company-notice-of-annual-general-meeting-of-the-company\/","og_site_name":"Pharma Trend","article_published_time":"2024-05-20T23:04:12+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20240520214893\/en\/1927844\/22\/AF-LOGO-AFYA-POSITIVO.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/afya-limited-the-company-notice-of-annual-general-meeting-of-the-company\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/afya-limited-the-company-notice-of-annual-general-meeting-of-the-company\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Afya Limited (the &#8220;Company&#8221;) Notice of Annual General Meeting of the Company","datePublished":"2024-05-20T23:04:12+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/afya-limited-the-company-notice-of-annual-general-meeting-of-the-company\/"},"wordCount":1016,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/afya-limited-the-company-notice-of-annual-general-meeting-of-the-company\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240520214893\/en\/1927844\/22\/AF-LOGO-AFYA-POSITIVO.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/afya-limited-the-company-notice-of-annual-general-meeting-of-the-company\/","url":"https:\/\/pharma-trend.com\/en\/afya-limited-the-company-notice-of-annual-general-meeting-of-the-company\/","name":"Afya Limited (the \"Company\") Notice of Annual General Meeting of the Company - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/afya-limited-the-company-notice-of-annual-general-meeting-of-the-company\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/afya-limited-the-company-notice-of-annual-general-meeting-of-the-company\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240520214893\/en\/1927844\/22\/AF-LOGO-AFYA-POSITIVO.jpg","datePublished":"2024-05-20T23:04:12+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/afya-limited-the-company-notice-of-annual-general-meeting-of-the-company\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/afya-limited-the-company-notice-of-annual-general-meeting-of-the-company\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/afya-limited-the-company-notice-of-annual-general-meeting-of-the-company\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20240520214893\/en\/1927844\/22\/AF-LOGO-AFYA-POSITIVO.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20240520214893\/en\/1927844\/22\/AF-LOGO-AFYA-POSITIVO.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/afya-limited-the-company-notice-of-annual-general-meeting-of-the-company\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Afya Limited (the &#8220;Company&#8221;) Notice of Annual General Meeting of the Company"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59400","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=59400"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59400\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=59400"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=59400"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=59400"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}